Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Fuel Selection During Eccentric Cycling With Glucose Ingestion

NCT03995693
completednot_applicable

Maple Products and Cognitive Performance During High Intensity Intermittent Exercise (HIIE)

NCT04084808
completednot_applicable

Maple Products and Exercise Performance

NCT02880124

Clinical Trials (3)

Showing 3 of 3 trials
NCT03995693Not Applicable

Fuel Selection During Eccentric Cycling With Glucose Ingestion

Completed
NCT04084808Not Applicable

Maple Products and Cognitive Performance During High Intensity Intermittent Exercise (HIIE)

Completed
NCT02880124Not Applicable

Maple Products and Exercise Performance

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3